DDD Partners’s ResMed RMD Stock Holding History

DDD Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$238K	Sell	1,061 -4	-0.4%	-$997	0.02%	125
2025 Q4	$257K	Buy	1,065 +2	+0.2%	+$511	0.02%	114
2025 Q3	$291K	Hold	1,063	–	–	0.02%	105
2025 Q2	$274K	Buy	1,063 +2	+0.2%	+$477	0.03%	100
2025 Q1	$238K	Sell	1,061 -2	-0.2%	-$467	0.03%	93
2024 Q4	$243K	Buy	1,063 +2	+0.2%	+$482	0.03%	89
2024 Q3	$259K	Hold	1,061	–	–	0.03%	92
2024 Q2	$203K	Hold	1,061	–	–	0.02%	92
2024 Q1	$210K	Buy	+1,061	New	+$194K	0.03%	86
2023 Q3	–	Sell	-1,165	Closed	-$255K	–	93
2023 Q2	$255K	Hold	1,165	–	–	0.04%	83
2023 Q1	$255K	Hold	1,165	–	–	0.04%	71
2022 Q4	$242K	Hold	1,165	–	–	0.04%	69
2022 Q3	$254K	Hold	1,165	–	–	0.05%	75
2022 Q2	$244K	Hold	1,165	–	–	0.04%	75
2022 Q1	$283K	Hold	1,165	–	–	0.04%	71
2021 Q4	$303K	Buy	+1,165	New	+$302K	0.04%	77

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DDD Partners's RMD Position: Q1 2026 in Review

DDD Partners reduced its ResMed (RMD) stake by 0.38% in Q1 2026, selling an estimated $997 and leaving 1,061 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #125.

DDD Partners first reported a position in RMD in Q4 2021 and has held it in 16 quarters since. The position peaked at $303K in Q4 2021. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

DDD Partners held 1,061 shares of ResMed worth $238K as of Q1 2026.
DDD Partners sold 4 ResMed shares in Q1 2026, an estimated $997.
ResMed made up 0.02% of DDD Partners's portfolio in Q1 2026, its #125 holding.
DDD Partners first reported a position in ResMed in Q4 2021 and has held it in 16 quarters since.
DDD Partners's ResMed position peaked at $303K in Q4 2021.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on DDD Partners's 13F filing for Q1 2026, filed 28 Apr 2026.